2197

COM:CLOVERBIOPHARMA

Clover Biopharmaceuticals

  • Stock

Last Close

0.29

22/11 03:08

Market Cap

415.27M

Beta: -

Volume Today

528.50K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
revenue
7.44M
-
7.44M
0%
128.50K
-
128.50K
0%
19.50M
15,074.32%
19.50M
0%
-5.05M
125.90%
-5.05M
0%
cost of revenue
33.13M
-
33.13M
0%
3.72M
88.77%
3.72M
0%
241.54M
6,391.33%
241.54M
0%
618.45M
156.04%
618.45M
0%
237.76M
61.56%
237.76M
0%
79K
99.97%
79K
0%
gross profit
-33.13M
-
-33.13M
0%
3.72M
111.23%
3.72M
0%
-241.54M
6,591.33%
-241.54M
0%
-618.32M
155.99%
-618.32M
0%
-218.26M
64.70%
-218.26M
0%
-5.13M
97.65%
-5.13M
0%
selling and marketing expenses
105.51M
-
11.26M
89.33%
11.26M
0%
16.13M
43.29%
16.13M
0%
3.34M
79.28%
3.34M
0%
general and administrative expenses
62.40M
-
62.40M
0%
110.45M
77.01%
110.45M
0%
112.67M
2.01%
112.67M
0%
92.45M
17.95%
92.45M
0%
54.73M
40.79%
54.73M
0%
44.67M
18.38%
44.67M
0%
21.04M
52.91%
21.04M
0%
selling general and administrative expenses
62.40M
-
62.40M
0%
110.45M
77.01%
110.45M
0%
112.67M
2.01%
112.67M
0%
92.45M
17.95%
92.45M
0%
65.99M
28.62%
65.99M
0%
60.80M
7.86%
60.80M
0%
24.38M
59.90%
24.38M
0%
research and development expenses
316.92M
-
316.92M
0%
596.23M
88.13%
596.23M
0%
427.63M
28.28%
427.63M
0%
305.03M
28.67%
305.03M
0%
192.80M
36.79%
192.80M
0%
132.14M
31.46%
132.14M
0%
49.15M
62.81%
49.15M
0%
other expenses
-495.17M
-
-1.40B
-
cost and expenses
655.48M
-
655.48M
0%
2.35B
259.12%
2.35B
0%
576.72M
75.50%
576.72M
0%
657.96M
14.09%
657.96M
0%
1.56B
137.56%
1.56B
0%
413.74M
73.53%
413.74M
0%
73.61M
82.21%
73.61M
0%
operating expenses
655.48M
-
655.48M
0%
2.32B
254.07%
2.32B
0%
573.00M
75.31%
573.00M
0%
416.42M
27.33%
416.42M
0%
944.60M
126.84%
944.60M
0%
175.99M
81.37%
175.99M
0%
73.53M
58.22%
73.53M
0%
interest expense
4.21M
-
13.29M
-
ebitda
-377.32M
-
-377.32M
0%
-735.89M
95.03%
-735.89M
0%
-547.26M
25.63%
-547.26M
0%
-621.28M
13.52%
-621.28M
0%
-871.59M
40.29%
-871.59M
0%
-415.82M
52.29%
-417.23M
0.34%
-69.71M
83.29%
-69.71M
0%
operating income
-379.34M
-
-379.34M
0%
-740.02M
95.08%
-740.02M
0%
-554.34M
25.09%
-554.34M
0%
-628.69M
13.41%
-628.69M
0%
-880.24M
40.01%
-880.24M
0%
-424.47M
51.78%
-424.47M
0%
-78.66M
81.47%
-78.66M
0%
depreciation and amortization
2.02M
-
2.02M
0%
4.13M
104.99%
4.13M
0%
7.08M
71.38%
7.08M
0%
7.41M
4.65%
7.41M
0%
8.65M
16.79%
8.65M
0%
8.65M
0%
7.25M
16.28%
9.04M
24.73%
9.04M
0%
total other income expenses net
-278.04M
-
-278.04M
0%
-1.61B
479.33%
-1.61B
0%
-13.70M
99.15%
-13.70M
0%
-29.22M
113.30%
-29.22M
0%
1.21B
4,225.50%
1.21B
0%
29.89M
97.52%
29.89M
0%
31.10M
4.03%
31.10M
0%
income before tax
-657.38M
-
-657.38M
0%
-2.35B
257.60%
-2.35B
0%
-568.04M
75.84%
-568.04M
0%
-657.91M
15.82%
-657.91M
0%
325.31M
149.45%
325.31M
0%
-394.58M
221.29%
-394.58M
0%
-47.56M
87.95%
-47.56M
0%
income tax expense
-3
-
3
-
-90.50K
-
-90.50K
0%
net income
-657.38M
-
-657.38M
0%
-2.35B
257.60%
-2.35B
0%
-568.04M
75.84%
-568.04M
0%
-657.91M
15.82%
-657.91M
0%
325.31M
149.45%
325.31M
0%
-394.58M
221.29%
-394.58M
0%
-47.56M
87.95%
-47.56M
0%
weighted average shs out
1.16B
-
1.08B
6.57%
1.08B
0%
1.12B
3.32%
1.12B
0%
1.25B
11.92%
1.25B
0%
1.25B
0.37%
1.25B
0%
1.19B
4.61%
1.19B
0%
weighted average shs out dil
1.16B
-
1.09B
6.20%
1.09B
0%
1.12B
2.91%
1.12B
0%
1.25B
11.47%
1.25B
0%
1.25B
0.04%
1.25B
0%
1.25B
0.43%
1.25B
0%
eps
0
-
0
0
-2.03
Infinity%
-0.53
73.89%
-0.53
0%
-0.59
11.32%
-0.59
0%
0.26
144.07%
0.26
0%
-0.32
223.08%
-0.32
0%
-0.04
87.50%
-0.04
0%
epsdiluted
0
-
0
0
-2.03
Infinity%
-0.52
74.38%
-0.52
0%
-0.59
13.46%
-0.59
0%
0.26
144.07%
0.26
0%
-0.32
223.08%
-0.32
0%
-0.04
88.13%
-0.04
0%

All numbers in (except ratios and percentages)